Flagship Labs, LLC
Records under this name other than patents Flagship Labs, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,987,791 | Compositions and Methods for Modulating Hepatocyte Nuclear Factor 4-Alpha (HNF4alpha) Gene Expression now held by Sepia Therapeutics, Inc. In force · High confidence | In force | High confidence | |
| US 11,978,538 | Systems and Methods for Associating Compounds with Properties Using Clique Analysis of Cell-Based Data conveyed to Flagship Pioneering Innovations VI, LLC In force · High confidence | In force | High confidence | |
| US 12,060,578 | Systems and Methods for Associating Compounds with Physiological Conditions Using Fingerprint Analysis conveyed to Flagship Pioneering Innovations VI, LLC In force · Medium confidence | In force | Medium confidence | |
| US 12,374,430 | Systems and Methods for Associating Compounds with Properties Using Clique Analysis of Cell-Based Data conveyed to Flagship Pioneering Innovations VI, LLC In force · High confidence | In force | High confidence | |
| US 11,654,121 | Combination Therapies for the Treatment of Viral Infections conveyed to Flagship Pioneering Innovations VI, LLC In force · High confidence | In force | High confidence | |
| US 12,338,474 | Compositions and Methods for Producing Circular Polyribonucleotides conveyed to Flagship Pioneering Innovations VI, LLC In force · High confidence | In force | High confidence | |
| US 12,303,526 | DNA Compositions and Related Methods conveyed to Flagship Pioneering Innovations VII, LLC In force · Medium confidence | In force | Medium confidence | |
| US 12,351,811 | Method for Modifying Plants with a Recombinant RNA Molecule conveyed to Flagship Pioneering Innovations VII, LLC In force · Medium confidence | In force | Medium confidence | |
| US 12,529,067 | Methods for Modifying Plants with a Recombinant RNA Molecule conveyed to Flagship Pioneering Innovations VII, LLC In force · Medium confidence | In force | Medium confidence | |
| US 12,110,324 | Antigen Binding Molecules Targeting Thymic Stromal Lymphopoietin (TSLP) conveyed to Flagship Pioneering Innovations VI, LLC In force · High confidence | In force | High confidence |